Christopher J. H. Porter

Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine

Shui‐Mei Khoo, Andrew Humberstone, Christopher J. H. Porter et al. · International Journal of Pharmaceutics · 1998 · 397 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products

Leab Sek, Christopher J. H. Porter, Ann Marie Kaukonen et al. · Journal of Pharmacy and Pharmacology · 2002 · 303 citations

Life Sciences, Biochemistry, Food Science +17

Effect of Short‐, Medium‐, and Long‐Chain Fatty Acid‐Based Vehicles on the Absolute Oral Bioavailability and Intestinal Lymphatic Transport of Halofantrine and Assessment of Mass Balance in Lymph‐Cannulated and Non‐cannulated Rats

Suzanne M. Caliph, William N. Charman, Christopher J. H. Porter · Journal of Pharmaceutical Sciences · 2000 · 293 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating

S. Moein Moghimi, Christopher J. H. Porter, I.S. Muir et al. · Biochemical and Biophysical Research Communications · 1991 · 281 citations

Pharmacy, Immunology, Pharmaceutics +10

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations

Hywel D. Williams, Philip Sassene, Karen Kleberg et al. · Journal of Pharmaceutical Sciences · 2012 · 269 citations

Pharmacy, Food Science, Pharmaceutical Analysis +17